STAT+: Pharmalittle: Novo Nordisk to spend $6 billion to boost production; FDA okays world’s first vaccine for chikungunya

Novo Nordisk announced a plan to spend a whopping $6 billion to expand its manufacturing capacity at its main production site in Denmark.
Click here to view original post